Liveris is trying to break Dowout of the boom-and-bust cycle of the chemical industry and turn it into a diversified provider of consistent earnings growth.
Blue-chip buyers returned to the markets by the close of trade Thursday, lifting the Dowout of the day-long doldrums, even as the lagging tech sector kept the Nasdaq from joining the festivities.